Akura Medical Secures $53 Million in Series C Financing for VTE Care Innovations Akura Medical, a portfolio company of Shifamed, has announced a successful Series C financing round, raising $53 million to enhance VTE care technologies.

Akura Medical Secures $53 Million in Series C Financing for VTE Care Innovations #USA #Los_Gatos #Shifamed #Akura_Medical #VTE_Care

Akura Medical Raises $53 Million in Series C Funding to Advance VTE Care Innovations Akura Medical has closed a $53 million Series C funding round to enhance development of innovative treatments for venous thromboembolism (VTE) care.

Akura Medical Raises $53 Million in Series C Funding to Advance VTE Care Innovations #USA #Los_Gatos #Shifamed #Akura_Medical #VTE_Care